Exercising during chemotherapy and before surgery may help the body send more immune cells into cancerous tumours, according to a first-of-its-kind pilot study from the University of Surrey and Royal Surrey NHS Foundation Trust. In a study published in the [...]
We are delighted to sponsor the MD fees for Dr William Hayhurst as he launches the LDR BURST trial at the Royal Surrey NHS Foundation NHS Trust. The trial will compare the side effects of Low Dose Rate Brachytherapy against [...]
Congratulations to Dr Nicola Annels who won the Azenta Life Sciences GENEWIZ Sequencing and Quantification Award! Dr Annels and her team's excellence and innovative work in advancing genomics research was recognised. This award enables Dr Annels to choose her preferred [...]
The REMOTE Study - An individualised 8-week remote exercise intervention to improve quality of life, cardiometabolic risk and physical activity level in men with prostate cancer undergoing androgen deprivation therapy (ADT) treatment. When one of our trustees, Dr Carla Perna [...]
Dr. David Bartlett is a Senior Lecturer of Exercise Immunology in the School of Biosciences and Medicine at the University of Surrey, he is also, just for good measure, an Adjunct Assistant Professor of Medicine at the world famous Duke [...]
Ground breaking cancer immunotherapy research at the University of Surrey has received a massive boost thanks to two the Prostate Project and BRIGHT.
We have created a report for the Targeted Cancer Therapy Group at the University of Surrey.
Some forms of cancer can become resistant to hormone therapy.
The best strategies for new treatment remain to be defined, but we need to look beyond traditional chemotherapy and radiotherapy.
The SUN study is an example of a successful project delivered with the support of Prostate Project charity.
